GlassScriptPhysician profile
Kimberly B Gordon
NPI 1952742660
$3,429.46
in general payments reported to CMS, 2019-2025
13 companies · $77.75 in 2025
The $77.75 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $361 · 2022: $196 · 2023: $175 · 2024: $2,620 · 2025: $77.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,016 · Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,016.19 |
| Food and Beverage | $856.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,348.51 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $234.51 | 2021-2024 | |
| Ethicon US, LLC | $196.17 | 2022-2024 | Echelon Flex, Stratafix |
| Novo Nordisk INC | $167.90 | 2021-2022 | |
| Inspire Medical Systems, INC. | $100.64 | 2023 | Inspire |
| Biohaven Pharmaceuticals, INC. | $93.49 | 2021 | |
| Integra Lifesciences Corporation | $90.28 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.57 | 2025 | Lifevest |
| Dexcom, INC. | $57.78 | 2023 | Dexcom G7 Gss (161) |
| Davol INC. | $28.94 | 2024 | Phasix Mesh |
| Smith+Nephew, INC. | $17.20 | 2024 | Collagenase Santyl |
| E.R. Squibb & Sons, L.L.C. | $16.29 | 2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $14.18 | 2025 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.